[Management of chronic hepatitis C which failed to respond to previous treatment].
Bronowicki
J-P
JP
Inserm U724, service d'hépatogastroentérologie, CHU de Nancy, 54500 Vandoeuvre-les-Nancy, France. jp.bronowicki@chu-nancy.fr
Nani
A
A
Barraud
H
H
D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D019233:Retreatment; D012254:Ribavirin / Q000627:therapeutic use*; D017211:Treatment Failure
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b